GVR Report cover Insulin Pump Market Size, Share & Trends Report

Insulin Pump Market Size, Share & Trends Analysis Report, By Type (Patch, Tethered), By Accessories (Insulin Reservoir Or Cartridges, Insulin Set Insertion Devices, Battery), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-3-68038-876-3
  • Number of Pages: 165
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Insulin Pump Market Size & Trends

The global insulin pump market size was valued at USD 4.1 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.8% from 2023 to 2030. The factors influencing market growth include technological advancements and the rising adoption of insulin pumps over traditional methods. Insulin pumps are quite practical for those who need several insulin injections each day. Because they are less intrusive, these devices are widely used by the patient population. The market's expansion is mostly attributable to the expanding elderly population, rising diabetes incidence, and rising obesity prevalence. To improve compliance and interaction with IT devices further, businesses are creating next-generation insulin pumps with cutting-edge technology, boosting the market's expansion. Technology advancements such as home infusion treatment and artificial pancreas are also projected to generate considerable growth prospects in the near future. Additionally, as the use of insulin pumps becomes more well-known, markets in developed and developing nations are expanding. 

U.S. Insulin Pump Market size and growth rate, 2023 - 2030

An increase in the incidence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the factors contributing to the growth of the market. Obesity is a major factor causing diabetes, leading to increased incidences of diabetes-associated ophthalmic disorders. Risk factors, such as obesity, smoking, and high cholesterol, are expected to boost the prevalence of type II diabetes.

Diabetes is increasing globally and is one of the leading causes of death, with an increased chance of acquiring various other health issues. The number of people diagnosed with type 1 diabetes is also rising, boosting market growth. Furthermore, the market is driven as people have become more aware of the disease of the growing senior population and increasingly sedentary lifestyles.

According to the IDF (International Diabetes Foundation) Atlas, diabetes will be responsible for around 6.7 million fatalities in 2021, and the overall number of diabetic patients is predicted to increase by 51% by 2045.

Increasing government initiatives for global awareness about Medicare policies and the management of diabetes are also fuelling market growth. Furthermore, there has been a rise in healthcare spending and an increase in the demand for improved tubeless insulin pumps that are both discreet and user-pleasant. This is expected to drive market growth during the forecast period.

When the pancreas is unable to produce enough insulin, diabetes develops when the body's glucose levels fall. Alcohol and cigarette use are two rapidly changing lifestyle choices contributing to a rise in diabetes cases worldwide. The increased incidence of diabetes is also largely attributed to the rising prevalence of obesity worldwide. The need for numerous insulin injections and continuous blood glucose monitoring due to type 1 diabetes (T1D) expands the market for pumps, alternative insulin delivery systems, and glucose monitors.

An insulin pump makes it possible to manually or automatically administer insulin. When necessary, such as before a meal, these pumps may give a larger set of insulin doses and a particular set of insulin doses. Patients can connect these devices to their smartphones to calibrate blood glucose readings. People with diabetes face many daily challenges, such as knowing what to eat, understanding medical advice, and the impact of food and activity on sugar.

With the increase in awareness regarding diabetes management and care, electronic insulin pumps are being favored by both doctors and consumers. This can be attributed to the fact that new-generation pumps are convenient, safe, and provide accurate results compared to traditional methods. The anytime-anywhere nature of digital technology enables patients to address their health issues by connecting with the healthcare team and sharing data. The aforementioned factors are expected to propel the growth of the market. Furthermore, the increasing number of initiatives undertaken by governments and nonprofit organizations to increase awareness about diabetes is expected to boost the adoption of insulin pumps used for the treatment.

Type Insights

The market is segmented into patch and tethered pumps based on the types. The tethered pumps segment dominated the market and accounted for the largest revenue share of 78% in 2022. This segment is expected to witness a CAGR of 9.8% during the forecast period. Tethered pumps have flexible tubing between the pump and the cannula. The large market size of the segment is majorly attributed to the reliability of these traditional pumps and the number of products available in the market.

The patch pump segment is expected to witness a robust CAGR of around 10.9% during the forecast period. Patch pumps are small and can be directly attached to the skin's surface. The market's high growth rate is mainly attributed to its benefits, such as no tubing in patch pumps and its remote control, which may also serve as a blood glucose meter. Moreover, pumps are integrated with calculators that help determine the exact insulin dosage required by patients. This helps reduce the over dosage of insulin and its associated effects. These factors are likely to boost the market's growth during the forecast period.

Product Insights

Medtronic’s MiniMed insulin pumps segment dominated the market and captured the largest revenue share of around 50.2% in 2022, owing to the high adoption rate and technological advancement. The growth of the MiniMed product line is primarily driven by a strong foothold and regional presence of Medtronic and the launch of its MiniMed 670G system, the world’s first hybrid closed-loop system.

The My Life Omnipod/ ypsomed pump segment is expected to exhibit the highest CAGR of 19.6% during the forecast period. Due to the absence of tubing, the omnipod system is preferred by many since it allows for greater exercise flexibility. Additionally, one does not need to stop taking insulin when showering or swimming.

Accessories Insights

The insulin set insertion devices segment dominated the market and accounted for the largest revenue share of 41.3% in 2022. The highest market share of this segment is majorly attributed to its use, such as in general infusion sets of insulin pumps being changed every two to three days and the high cost of infusion sets. 

Global Insulin Pump Market share and size, 2022

The insulin reservoir or cartridges segment is expected to witness a substantial growth rate of CAGR of 10% during the forecast period. The increasing adoption of tethered pumps drives the growth of the segment. This typically involves loading a cartridge of insulin into the reservoir or drawing insulin from a vial into the reservoir. These reservoirs can hold up to 300 units of insulin and do not require a change for at least 2-3 days. The aforementioned factors are expected to drive the growth of the segment.

End-use Insights

The hospitals and clinics segment dominated the market and accounted for the largest revenue share of 44.6% in 2022. The large share of the segment is attributed to the availability of skilled healthcare professionals, increasing government funding, and rising private sector investment in the healthcare sector.

The homecare segment is expected to witness the fastest CAGR of 10.2% during the forecast period. The sector's growth is attributed to the increasing awareness about insulin pump use and the high adoption of these products at home due to their ease of use. Moreover, increasing usage of patch pumps, which are small and easy to carry, is also expected to propel the market during the forecast period.

Regional Insights

North America dominated the insulin pump market and captured the largest revenue share of around 45.8% in 2022, owing to major players in insulin pumps. Furthermore, the increasing prevalence of obesity, high treatment costs, technological advancement, and product launches are also expected to drive the market in the region. Europe is also expected to capture a significant market share over the forecast period due to an increase in the geriatric population, which is prone to diabetes. Moreover, improvements in its healthcare sector and the implementation of advanced medical products are augmenting the demand for insulin pumps in the region.

Insulin Pump Market Trends, by Region, 2023 - 2030

Asia Pacific is projected to be a lucrative region for the insulin pumps market. Increasing healthcare funding and government initiatives to spread awareness about diabetes are major factors aiding growth in this region. China is expected to lead the Asia Pacific region in 2022 owing to its economic growth and large diabetes population. Furthermore, adopting new technology in developing economies is also anticipated to boost the market.

Competitive Insights

Key players are involved in adopting strategies such as mergers and acquisitions, partnerships, and the launch of new technologically advanced products and services to strengthen their foothold in the market. Key players are significantly investing in research and development to manufacture technologically advanced products. For instance, in June 2019, Medtronic announced its partnership with Tidepool to create an interoperable automated insulin pump system. The former plans to launch a new Bluetooth-enabled MiniMed insulin pump, which will be compatible with Tidepool Loop, a hybrid. On June 2, 2022, Insulet Corporation, a world leader in tubeless insulin pump devices and technology, announced an investment of approximately USD 200 million in its upcoming manufacturing facility in Johor over the next five years. This would produce the company’s Omnipod Insulin Management System as part of its ambition to strengthen its worldwide manufacturing capabilities

In April 2022, Ypsomed announced a collaboration with Abbott and CamDiab to develop an integrated AID (automated insulin delivery) system. The new integrated AID system is being designed to link Abbott's FreeStyle Libre 3 with Ypsomed's MyLife YpsoPump to make a smart, and automatic procedure for delivering insulin with realistic glucose data

On 3 June 2022, Diabeloop, a world leader in therapeutic AI, and SOOIL Development Company, a leader in superior diabetes therapy announced an agreement for worldwide development at the American Diabetes Association Scientific Sessions. The collaboration is anticipated to establish clinical trials for expanding their cooperation and provide access to their goods to as many patients as possible through new innovative products.

Key Insulin Pump Companies:

  • Medtronic plc
  • Hoffmann-La Roche Ltd
  • Tandem Diabetic Care, Inc.
  • Insulet Corporation
  • Ypsomed
  • Cellenovo
  • Sooil Development
  • Valeritas, Inc
  • JingasuDelfu Co., Ltd.

Insulin Pump Market Report Scope

Report Attribute


Market size value in 2023

USD 4.4 billion

Revenue forecast in 2030

USD 8.6 billion

Growth rate

CAGR of 9.8% from 2023 to 2030

Base year for estimation


Historical data

2018 - 2021

Forecast period

2023 - 2030

Report updated

December 2023

Quantitative units

Revenue in USD million and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, product, accessories, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait

Key companies profiled

Medtronic plc; Hoffmann-La Roche Ltd; Tandem Diabetic Care, Inc.; Insulet Corporation; Ypsomed; Cellenovo; Sooil Development; Valeritas, Inc; JingasuDelfu Co., Ltd.


Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Global Insulin Pump Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global Insulin pump marketbased on type, material, application, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Patch pumps

    • Tethered pumps

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • MiniMed (630G, 670G, and VEO)

    • Accu-Chek (Combo, Insight, and Solo)

    • Tandem (T: slim X2, G4, T: flex Delivery System)

    • Omnipod

    • My life omnipod

    • Others

  • Accessories Outlook (Revenue, USD Million, 2018 - 2030)

    • Insulin reservoir or cartridges

    • Insulin set insertion devices

    • Battery

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Hospitals & clinics

    • Homecare

    • Laboratories

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Sweden

      • Norway

      • Denmark

    • Asia Pacific

      • China

      • Japan

      • India

      • Australia

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa

      • Saudi Arabia

      • South Africa

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.